Insider Trading Alert - MED, MATR And IPGP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 4, 2015, 76 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $203.25 to $160,379,000.00.

Highlighted Stocks Traded by Insiders:

Medifast (MED) - FREE Research Report

Bondroff Barry B, who is Director at Medifast, sold 10,713 shares at $32.71 on June 4, 2015. Following this transaction, the Director owned 16,199 shares meaning that the stake was reduced by 39.81% with the 10,713-share transaction.

The shares most recently traded at $31.80, down $0.91, or 2.87% since the insider transaction. Historical insider transactions for Medifast go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 3,000

The average volume for Medifast has been 110,700 shares per day over the past 30 days. Medifast has a market cap of $396.0 million and is part of the services sector and specialty retail industry. Shares are down 3.67% year-to-date as of the close of trading on Thursday.

Medifast, Inc. engages in the production, distribution, and sale of weight loss and weight management products and other consumable health and diet products. The company has a P/E ratio of 21.5. Currently, there are no analysts who rate Medifast a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MED - FREE

TheStreet Quant Ratings rates Medifast as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and increase in stock price during the past year. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medifast Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Beach Season Already? Medifast Is Ready to Help You Get in Shape

Beach Season Spurring Sales Says Medifast CEO

Insider Trading Alert - MED, SNAK And UNXL Traded By Insiders

New Year's Resolution Season Busy Time for Weight Loss Industry, Says Medifast CEO

Oprah Adding Heft to Resolution Season Says Medifast CEO